Valeria Canto-Soler, PhD, has an innovative vision for saving and restoring sight in patients with blinding diseases. An associate professor in the CU School of Medicine’s Department of Ophthalmology, Canto-Soler is the director of CellSight, an innovative ocular stem cell and regeneration research program.
Related Articles
Zynex, Inc. Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communication Program
ENGLEWOOD, Colo., July 10, 2023 /PRNewswire/ — Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, has engaged […]
GHX Recognizes Advancement in Supply Chain Automation with 2024 Millennium Club Honorees
Celebrating Healthcare Industry Leaders for Transforming Supply Chain Efficiency with Automation LOUISVILLE, Colo., March 25, 2025 /PRNewswire/ — Global Healthcare Exchange (GHX) is proud to announce the 2024 Millennium Club honorees, recognizing 94 forward-thinking healthcare […]
Healthy Smart Mart™ Revolutionizes Break Rooms with Contactless Shopping Experience
FORT COLLINS, Colo., July 1, 2024 /PRNewswire/ — Healthy Smart Mart™, a leading innovator in workplace refreshment solutions, is proud to announce its latest breakthrough in break room technology: the introduction of a fully contactless […]
